PureTech Health noted that its Founded Entity, Karuna Therapeutics announced the submission of a new drug application, or NDA, to the FDA for KarXT for the treatment of schizophrenia.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on PRTC:
- PureTech Health appoints Robert Lyne as chief portfolio officer
- PureTech Health participates in a conference call hosted by Jefferies
- DoD awards PureTech $11.4M to advance LYT-300 for FXTAS treatment
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue